Travis Bond, Altoida - Studio Interview | LSI Europe ‘22

Altoida is using technology to predict the onset of neurlogical diseases, such as Alzheimer's disease, before symptoms occur. The company's platform evaluates an individual's risk by interrogating 800 digital biomarkers collected through a digital assessment and augmented reality (AR).